These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 37963238)
21. Boosting open-label placebo effects in acute induced pain in healthy adults (BOLPAP-study): study protocol of a randomized controlled trial. de Leeuw M; Laager M; Gaab J; Ruppen W; Schneider T Front Med (Lausanne); 2024; 11():1238878. PubMed ID: 38420356 [TBL] [Abstract][Full Text] [Related]
22. Open-label placebo treatment to improve relaxation training effects in healthy psychology students: a randomized controlled trial. Schienle A; Unger I Sci Rep; 2021 Jun; 11(1):13073. PubMed ID: 34158569 [TBL] [Abstract][Full Text] [Related]
23. Even when you know it is a placebo, you experience less sadness: First evidence from an experimental open-label placebo investigation. Hahn A; Göhler AC; Hermann C; Winkler A J Affect Disord; 2022 May; 304():159-166. PubMed ID: 35181385 [TBL] [Abstract][Full Text] [Related]
24. Open-label placebo clinical trials: is it the rationale, the interaction or the pill? Blease CR; Bernstein MH; Locher C BMJ Evid Based Med; 2020 Oct; 25(5):159-165. PubMed ID: 31243047 [TBL] [Abstract][Full Text] [Related]
25. [Appearances are not deceptive: clinical evidence and new research approaches to open-label placebo]. Nestoriuc Y; Kleine-Borgmann J Nervenarzt; 2020 Aug; 91(8):708-713. PubMed ID: 32691079 [TBL] [Abstract][Full Text] [Related]
26. Open-label versus double-blind placebo treatment in irritable bowel syndrome: study protocol for a randomized controlled trial. Ballou S; Kaptchuk TJ; Hirsch W; Nee J; Iturrino J; Hall KT; Kelley JM; Cheng V; Kirsch I; Jacobson E; Conboy L; Lembo A; Davis RB Trials; 2017 May; 18(1):234. PubMed ID: 28545508 [TBL] [Abstract][Full Text] [Related]
27. Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia. Locher C; Frey Nascimento A; Kirsch I; Kossowsky J; Meyer A; Gaab J Pain; 2017 Dec; 158(12):2320-2328. PubMed ID: 28708766 [TBL] [Abstract][Full Text] [Related]
36. Primary care providers' use of and attitudes towards placebos: An exploratory focus group study with US physicians. Bernstein MH; Locher C; Stewart-Ferrer S; Buergler S; DesRoches CM; Dossett ML; Miller FG; Grose D; Blease CR Br J Health Psychol; 2020 Sep; 25(3):596-614. PubMed ID: 32472982 [TBL] [Abstract][Full Text] [Related]
37. No acute effects of placebo or open-label placebo treatments on strength, voluntary activation, and neuromuscular fatigue. Swafford AP; Kwon DP; MacLennan RJ; Fukuda DH; Stout JR; Stock MS Eur J Appl Physiol; 2019 Oct; 119(10):2327-2338. PubMed ID: 31468171 [TBL] [Abstract][Full Text] [Related]
38. Open-Label Placebo Treatment for Acute Postoperative Pain (OLP-POP Study): Study Protocol of a Randomized Controlled Trial. Sezer D; de Leeuw M; Netzer C; Dieterle M; Meyer A; Buergler S; Locher C; Ruppen W; Gaab J; Schneider T Front Med (Lausanne); 2021; 8():687398. PubMed ID: 34805194 [No Abstract] [Full Text] [Related]
39. Effects of open-label placebos on test performance and psychological well-being in healthy medical students: a randomized controlled trial. Kleine-Borgmann J; Schmidt K; Billinger M; Forkmann K; Wiech K; Bingel U Sci Rep; 2021 Jan; 11(1):2130. PubMed ID: 33483552 [TBL] [Abstract][Full Text] [Related]
40. The pill you don't have to take that is still effective: neural correlates of imaginary placebo intake for regulating disgust. Schienle A; Kogler W; Seibel A; Wabnegger A Soc Cogn Affect Neurosci; 2024 Mar; 19(1):. PubMed ID: 38450743 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]